Davis Andrew 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed May 22, 2024
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Sale
Class A Common Stock
2024-05-20$6.45/sh−22,725$146,576→ 288,031 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.